HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiang-Mei Chen Selected Research

shenle

12/2006[Prospective, multi-centered, randomized and controlled trial on effect of Shenle Capsule in treating patients with IgA nephropathy of Fei-Pi qi-deficiency syndrome].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiang-Mei Chen Research Topics

Disease

15IGA Glomerulonephritis (IGA Nephropathy)
03/2020 - 03/2006
13Proteinuria
01/2021 - 12/2006
11Chronic Renal Insufficiency
01/2022 - 02/2013
9Acute Kidney Injury (Acute Renal Failure)
01/2021 - 01/2011
7Fibrosis (Cirrhosis)
07/2022 - 06/2004
7Diabetic Nephropathies (Diabetic Nephropathy)
02/2022 - 01/2014
7Kidney Diseases (Kidney Disease)
03/2020 - 01/2015
5Chronic Kidney Failure (Chronic Renal Failure)
01/2019 - 02/2017
5Neoplasms (Cancer)
05/2018 - 11/2010
4Hypertension (High Blood Pressure)
01/2020 - 02/2007
4Diabetes Mellitus
01/2019 - 11/2010
4Disease Progression
02/2017 - 01/2009
3Anemia
01/2022 - 01/2013
3Nephrotic Syndrome (Syndrome, Nephrotic)
03/2020 - 05/2012
3Inflammation (Inflammations)
02/2019 - 06/2014
3Infections
01/2019 - 12/2010
2Hypertrophy
02/2022 - 01/2012
2Reperfusion Injury
01/2021 - 01/2019
2Hypoxia (Hypoxemia)
08/2020 - 07/2013
2Sclerosis
03/2020 - 08/2005
2Membranous Glomerulonephritis (Membranous Nephropathy)
03/2020 - 01/2018
2Atrophy
01/2019 - 08/2005
2Insulin Resistance
04/2018 - 09/2015
2Hematuria
01/2017 - 02/2007
2Necrosis
12/2016 - 01/2011
2Atherosclerosis
08/2012 - 10/2010
2Yin Deficiency (Yinxu)
02/2007 - 03/2006
1Mitochondrial Diseases (Mitochondrial Disease)
06/2022
1Lung Diseases (Lung Disease)
02/2022
1Wounds and Injuries (Trauma)
02/2022
1Type 2 Diabetes Mellitus (MODY)
01/2022
1Ureteral Obstruction
01/2022
1Malnutrition (Nutritional Deficiencies)
05/2021
1Glomerulonephritis
01/2021
1Pruritus (Itching)
11/2020
1Fabry Disease (Fabry's Disease)
07/2020
1Stroke (Strokes)
01/2020
1Cognitive Dysfunction
01/2020
1Water Intoxication
11/2019

Drug/Important Bio-Agent (IBA)

17CreatinineIBA
03/2020 - 08/2005
13Proteins (Proteins, Gene)FDA Link
07/2022 - 03/2006
7MicroRNAs (MicroRNA)IBA
01/2021 - 03/2016
6Biomarkers (Surrogate Marker)IBA
01/2021 - 03/2016
5Glucose (Dextrose)FDA LinkGeneric
06/2022 - 01/2012
5Cisplatin (Platino)FDA LinkGeneric
01/2021 - 02/2012
5Urea (Carbamide)FDA LinkGeneric
01/2019 - 03/2006
4Uric Acid (Urate)IBA
05/2021 - 08/2016
4AlbuminsIBA
11/2019 - 01/2013
4Immunoglobulin A (IgA)IBA
02/2017 - 03/2006
4NitrogenIBA
12/2016 - 03/2006
3TabletsIBA
01/2021 - 02/2007
3Pharmaceutical PreparationsIBA
01/2021 - 07/2019
3TOR Serine-Threonine KinasesIBA
01/2019 - 01/2012
3Triglycerides (Triacylglycerol)IBA
01/2019 - 08/2005
3Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2011 - 08/2005
2Leucine (L-Leucine)FDA Link
01/2022 - 07/2013
2Losartan (Cozaar)FDA LinkGeneric
01/2021 - 11/2017
2Therapeutic UsesIBA
11/2020 - 11/2018
2GalactosidasesIBA
07/2020 - 11/2013
2Hemoglobins (Hemoglobin)IBA
11/2019 - 01/2017
2shenhuaIBA
01/2019 - 02/2007
2AMP-Activated Protein KinasesIBA
01/2019 - 11/2018
2Serum AlbuminIBA
01/2018 - 05/2012
2Tacrolimus (Prograf)FDA LinkGeneric
01/2018 - 05/2012
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2017 - 02/2007
2Angiotensin Receptor AntagonistsIBA
11/2017 - 09/2015
2Fibrinogen (Factor I)FDA Link
09/2015 - 08/2005
2AnticoagulantsIBA
04/2015 - 01/2011
2Connexin 43 (Connexin43)IBA
03/2014 - 01/2012
2Fosinopril (Monopril)FDA LinkGeneric
02/2007 - 12/2006
1InflammasomesIBA
06/2022
1Electron Transport Complex IV (Cytochrome c Oxidase)IBA
06/2022
1Adenosine Triphosphate (ATP)IBA
06/2022
1ginsenoside Rb1IBA
02/2022
1Streptozocin (Streptozotocin)FDA Link
02/2022
1HematinicsIBA
01/2022
1aristolochic acid I (aristolochic acid)IBA
01/2022
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1Nonprescription Drugs (Patent Medicines)IBA
01/2021
1Gentamicins (Gentamicin)FDA LinkGeneric
01/2021
1sodium thiosulfateFDA Link
11/2020
1Loratadine (Alavert)FDA Link
11/2020
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
08/2020
1Sorbitol (Yal)FDA Link
08/2020
1Complement System Proteins (Complement)IBA
03/2020
1Phospholipase A2 ReceptorsIBA
03/2020
1AntibodiesIBA
03/2020
1Interleukin-6 (Interleukin 6)IBA
11/2019
1Transcription Factors (Transcription Factor)IBA
07/2019
1IntegrinsIBA
07/2019
1UbiquitinIBA
02/2019
1ChemokinesIBA
02/2019

Therapy/Procedure

10Therapeutics
01/2022 - 01/2009
5Renal Dialysis (Hemodialysis)
01/2022 - 01/2013
2Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2022 - 11/2017
2Caloric Restriction
08/2020 - 01/2015
2Glycemic Control
03/2020 - 01/2013
2Drug Therapy (Chemotherapy)
01/2018 - 01/2011
1Bronchoscopes
02/2022